热门资讯> 正文
自行车治疗报告第一季度业绩
2025-05-01 22:14
- Bicycle Therapeutics press release (NASDAQ:BCYC): Q1 GAAP EPS of -$0.88
- Revenue of $10M (-48.8% Y/Y).
- Cash and cash equivalents were $793.0 million as of March 31, 2025, compared to $879.5 million as of December 31, 2024.
More on Bicycle Therapeutics
- Bicycle Therapeutics: Maybe Underwhelming, But I Don't Think They Should Be This Discounted
- Bicycle Therapeutics: Trading At Cash, Underwhelming But Not Unsalvageable Data
- Seeking Alpha’s Quant Rating on Bicycle Therapeutics
- Historical earnings data for Bicycle Therapeutics
- Financial information for Bicycle Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
